Anna C Frauenheim, Kerri L Wiggins, Rozenn N Lemaitre, Nicholas L Smith, Laura B Harrington
{"title":"在一个以人群为基础的初始队列中,静脉血栓栓塞前的身体活动和复发风险。","authors":"Anna C Frauenheim, Kerri L Wiggins, Rozenn N Lemaitre, Nicholas L Smith, Laura B Harrington","doi":"10.1007/s11239-025-03127-w","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>The association between moderate-to-vigorous physical activity (MVPA) and recurrent venous thromboembolism (VTE) is unclear, but an improved understanding could inform behavioral health recommendations.</p><p><strong>Methods: </strong>The Heart and Vascular Health study, set in a large integrated healthcare system, identified adults with a validated incident VTE between January 2002 and December 2010. An inception cohort was formed from these cases and followed for a first recurrent VTE through December 2014. Usual MVPA pre-incident VTE was self-reported by 1381 adults via telephone interview, and MVPA amount was calculated in metabolic equivalent of task (MET) hours (h) per week. Multivariable-adjusted Cox proportional hazards models estimated adjusted hazard ratios (HR<sub>adj</sub>) for any MVPA versus none and MVPA amount, continuously and in quartiles, in MET-h/week among participants reporting any MVPA. Secondary analyses separately evaluated MET-h/week, by intensity.</p><p><strong>Results: </strong>During follow-up (median = 5.23 years), 288 (20.9%) individuals developed a recurrent VTE. There was no evidence of an association between any MVPA versus none and VTE recurrence (HR<sub>adj</sub>=1.24, [95% confidence interval [CI]: 0.80, 1.91]). Among participants with any MVPA, there was no evidence of an association between MVPA in MET-h/week (HR<sub>adj</sub> per 7.5 MET-h/week = 1.00, [95% CI: 0.98, 1.03]), nor quartiles of MVPA (p-trend = 0.62) with VTE recurrence risk. In secondary analyses there was no evidence of an association of MET-h/week of moderate or vigorous physical activity (PA) with VTE recurrence.</p><p><strong>Conclusions: </strong>In this cohort of adults who experienced incident VTE, there was no evidence of an association between self-reported MVPA pre-incident VTE and VTE recurrence risk.</p>","PeriodicalId":17546,"journal":{"name":"Journal of Thrombosis and Thrombolysis","volume":" ","pages":""},"PeriodicalIF":2.2000,"publicationDate":"2025-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Physical activity before venous thromboembolism and risk of recurrence in a population-based inception cohort.\",\"authors\":\"Anna C Frauenheim, Kerri L Wiggins, Rozenn N Lemaitre, Nicholas L Smith, Laura B Harrington\",\"doi\":\"10.1007/s11239-025-03127-w\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>The association between moderate-to-vigorous physical activity (MVPA) and recurrent venous thromboembolism (VTE) is unclear, but an improved understanding could inform behavioral health recommendations.</p><p><strong>Methods: </strong>The Heart and Vascular Health study, set in a large integrated healthcare system, identified adults with a validated incident VTE between January 2002 and December 2010. An inception cohort was formed from these cases and followed for a first recurrent VTE through December 2014. Usual MVPA pre-incident VTE was self-reported by 1381 adults via telephone interview, and MVPA amount was calculated in metabolic equivalent of task (MET) hours (h) per week. Multivariable-adjusted Cox proportional hazards models estimated adjusted hazard ratios (HR<sub>adj</sub>) for any MVPA versus none and MVPA amount, continuously and in quartiles, in MET-h/week among participants reporting any MVPA. Secondary analyses separately evaluated MET-h/week, by intensity.</p><p><strong>Results: </strong>During follow-up (median = 5.23 years), 288 (20.9%) individuals developed a recurrent VTE. There was no evidence of an association between any MVPA versus none and VTE recurrence (HR<sub>adj</sub>=1.24, [95% confidence interval [CI]: 0.80, 1.91]). Among participants with any MVPA, there was no evidence of an association between MVPA in MET-h/week (HR<sub>adj</sub> per 7.5 MET-h/week = 1.00, [95% CI: 0.98, 1.03]), nor quartiles of MVPA (p-trend = 0.62) with VTE recurrence risk. In secondary analyses there was no evidence of an association of MET-h/week of moderate or vigorous physical activity (PA) with VTE recurrence.</p><p><strong>Conclusions: </strong>In this cohort of adults who experienced incident VTE, there was no evidence of an association between self-reported MVPA pre-incident VTE and VTE recurrence risk.</p>\",\"PeriodicalId\":17546,\"journal\":{\"name\":\"Journal of Thrombosis and Thrombolysis\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.2000,\"publicationDate\":\"2025-09-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Thrombosis and Thrombolysis\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s11239-025-03127-w\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Thrombosis and Thrombolysis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11239-025-03127-w","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
Physical activity before venous thromboembolism and risk of recurrence in a population-based inception cohort.
Introduction: The association between moderate-to-vigorous physical activity (MVPA) and recurrent venous thromboembolism (VTE) is unclear, but an improved understanding could inform behavioral health recommendations.
Methods: The Heart and Vascular Health study, set in a large integrated healthcare system, identified adults with a validated incident VTE between January 2002 and December 2010. An inception cohort was formed from these cases and followed for a first recurrent VTE through December 2014. Usual MVPA pre-incident VTE was self-reported by 1381 adults via telephone interview, and MVPA amount was calculated in metabolic equivalent of task (MET) hours (h) per week. Multivariable-adjusted Cox proportional hazards models estimated adjusted hazard ratios (HRadj) for any MVPA versus none and MVPA amount, continuously and in quartiles, in MET-h/week among participants reporting any MVPA. Secondary analyses separately evaluated MET-h/week, by intensity.
Results: During follow-up (median = 5.23 years), 288 (20.9%) individuals developed a recurrent VTE. There was no evidence of an association between any MVPA versus none and VTE recurrence (HRadj=1.24, [95% confidence interval [CI]: 0.80, 1.91]). Among participants with any MVPA, there was no evidence of an association between MVPA in MET-h/week (HRadj per 7.5 MET-h/week = 1.00, [95% CI: 0.98, 1.03]), nor quartiles of MVPA (p-trend = 0.62) with VTE recurrence risk. In secondary analyses there was no evidence of an association of MET-h/week of moderate or vigorous physical activity (PA) with VTE recurrence.
Conclusions: In this cohort of adults who experienced incident VTE, there was no evidence of an association between self-reported MVPA pre-incident VTE and VTE recurrence risk.
期刊介绍:
The Journal of Thrombosis and Thrombolysis is a long-awaited resource for contemporary cardiologists, hematologists, vascular medicine specialists and clinician-scientists actively involved in treatment decisions and clinical investigation of thrombotic disorders involving the cardiovascular and cerebrovascular systems. The principal focus of the Journal centers on the pathobiology of thrombosis and vascular disorders and the use of anticoagulants, platelet antagonists, cell-based therapies and interventions in scientific investigation, clinical-translational research and patient care.
The Journal will publish original work which emphasizes the interface between fundamental scientific principles and clinical investigation, stimulating an interdisciplinary and scholarly dialogue in thrombosis and vascular science. Published works will also define platforms for translational research, drug development, clinical trials and patient-directed applications. The Journal of Thrombosis and Thrombolysis'' integrated format will expand the reader''s knowledge base and provide important insights for both the investigation and direct clinical application of the most rapidly growing fields in medicine-thrombosis and vascular science.